Tenon Medical, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | — | $3.9M | $3.3M | $2.9M | $691.0K | $160.0K |
| Cost of Revenue | — | $1.6M | $1.6M | $1.7M | $1.3M | $55.0K |
| Gross Profit | — | $2.4M | $1.7M | $1.2M | $-641.0K | $105.0K |
| Gross Margin | — | 59.8% | 52.2% | 42.4% | -92.8% | 65.6% |
| Operating Expenses | ||||||
| Research & Development | — | $2.1M | $2.6M | $3.2M | $2.8M | $1.7M |
| SG&A Expense | — | $7.0M | $7.8M | $7.0M | $7.4M | $2.7M |
| Operating Income | — | $-12.8M | $-13.8M | $-15.7M | $-18.7M | $-6.5M |
| Operating Margin | — | -324.3% | -420.1% | -537.1% | -2,709.8% | -4,038.1% |
| Interest Expense | — | — | — | $21.0K | $354.0K | $621.0K |
| Pretax Income | — | — | — | — | $-18.9M | $-7.1M |
| Income Tax Expense | — | — | — | — | — | — |
| Net Income | — | $-12.6M | $-13.7M | $-15.6M | $-18.9M | $-7.0M |
| Net Margin | — | -318.4% | -417.2% | -532.1% | -2,737.6% | -4,405.0% |
| EPS (Basic) | — | $-1.70 | $-1.88 | $-2.29 | $-0.79 | $-0.26 |
| EPS (Diluted) | — | $-1.70 | $-1.88 | $-2.29 | $-0.79 | $-0.26 |
| Shares Outstanding (Basic) | 11.3M | 7.4K | 7.3K | 6.8K | 24.0K | 27.1K |
| Shares Outstanding (Diluted) | 11.3M | 7.4K | 7.3K | 6.8K | 24.0K | 27.1K |
| Dividends Per Share | — | — | — | — | — | — |